Insider · CIK 0001848372
Arsani William
Files at DSGN (Design Therapeutics, Inc.). First filing Aug 14, 2025, latest Aug 14, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DSGN: Design Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | DSGNsell Design Therapeutics, Inc. | $3.0M 562,627 shares | -19% | +94% from low-28% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | DSGN Design Therapeutics, Inc. | SOpen-market sale Common Stockindirect: By Logos Global Master Fund LP | -345,000 | $5.25 | $1.8M | 2,655,000 | Aug 14, 2025 |
| Aug 13, 2025 | DSGN Design Therapeutics, Inc. | SOpen-market sale Common Stockindirect: By Logos Opportunities Fund II LP | -217,627 | $5.25 | $1.1M | 1,000,000 | Aug 14, 2025 |
| Jun 10, 2025 | DSGN Design Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.